PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26952513-0	2016	Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.	Erlotinib Hydrochloride	120-129	albumin	Homo sapiens	0-13	
26952513-3	2016	The aim of our retrospective study was to evaluate the association of baseline serum albumin with outcomes in a large cohort of patients with advanced-stage NSCLC treated with erlotinib.	Erlotinib Hydrochloride	176-185	albumin	Homo sapiens	79-92